System integrates artificial intelligence to maximize conventional and spectral CT capabilities.
Canon Medical Systems received 510(k) clearance from the U.S. Food and Drug Administration on Wednesday for the Aquilion ONE/PRISM Edition.
This system, designed for deep intelligence, integrates artificial intelligence technology to maximize conventional and spectral CT automated workflow capabilities, as well as provide clinic insights to support patient-care decision-making.
The Aquilion ONE/PRISM Edition uses the Advanced Intelligent Clear-IQ Engine (AiCE) for CT reconstruction. The product, which is trained on a significant amount of high-quality image data, employs deep learning to differentiate between true signal and noise to deliver clear images quickly.
“Canon Medical’s DLR technology is pushing routine diagnostic imaging into the age of AI assisted imaging, revolutionizing patient care by enabling excellent diagnostic confidence,” said Erin Angel, managing director of Canon Medical’s CT Business Unit. “With Deep Learning Spectral, Canon Medical is able to provide clinicians with a spectral CT system designed to address the trade-offs of traditional spectral CT and, potentially, expand the utilization to more routine CT imaging.”
AiCE can be applied, according to the company statement, to enhance the anatomical resolution for the whole body, including brain, lung, cardiac, and musculoskeletal applications. And, Aquilion ONE/PRISM Edition supports more confident diagnoses with rapid kV switching with patient-specific mA modulation, full field-of-view acquisition, and 16cm coverage. The end-to-end workflow can be integrated into routine protocols, company officials said.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.